Program - Oral Presentations 44: Pharmacogenomics 2

Oral Presentations 44: Pharmacogenomics 2

Tracks

Track 4

Thursday, July 16, 2026

2:30 PM - 4:00 PM

Speaker

Agenda Item Image

Miss Deirdre Landsberg

Adelaide University

Clinical integration of pre-emptive DPYD genotype testing services in a tertiary hospital

Abstract

Biography

Agenda Item Image

Dr Janet Coller

University of Adelaide

MTHFR genetic variability contributes to gastrointestinal toxicity following 5-fluoropyrimidine‐based chemotherapy

Abstract

Biography

Agenda Item Image

Mr Britto Shajan

Flinders University

The Effects of Genetic Variant C182F on TAAR1 Structure and Function

Abstract

Biography

Agenda Item Image

Dr Dilanka Fernando

Monash University

Pharmacogenetic Insights into Encaleret Dosing for Autosomal Dominant Hypocalcemia Type 1

Abstract

Biography

Agenda Item Image

Dr Julian Peter Müller

Institute Of Clinical Pharmacology, University Hospital RWTH Aachen

Pantoprazole metabolic ratio as a novel CYP2C19 phenotyping method

Abstract

Biography

Agenda Item Image

Ms Noora Kulla

University Of Turku

Assessing Pharmacists’ Understanding on Pharmacogenetic Testing: Survey of Perspectives and Educational Needs

Abstract

Biography

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript